Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 27.04
+1.03 (3.96%)
Sep 30, 2026, 3:00 PM CST
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 11.61 billion as of October 2, 2026. Its market cap has decreased by -40.04% in one year.
Market Cap
11.61B
Enterprise Value
12.78B
Revenue
873.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.04
ChartMarket Cap Chart
Since January 18, 2022, SHA:688062's market cap has increased from 9.79B to 11.61B, an increase of 18.56%. That is a compound annual growth rate of 3.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 11.61B | -24.46% |
| Dec 31, 2025 | 15.36B | 90.35% |
| Dec 31, 2024 | 8.07B | -38.21% |
| Dec 29, 2023 | 13.06B | 126.23% |
| Dec 30, 2022 | 5.77B | -41.02% |
| Jan 18, 2022 | 9.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 12.58B |
| Jinyu Bio-technology | 12.46B |
| Inner Mongolia Furui Medical Science | 12.10B |
| Hualan Biological Vaccine | 11.97B |
| Shanghai OPM Biosciences | 11.32B |
| Novoprotein Scientific | 11.15B |
| Tibet Cheezheng Tibetan Medicine | 10.99B |
| InventisBio | 10.55B |